Litigation Details for Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-12-20 |
| Court | District Court, D. Delaware | Date Terminated | 2019-05-08 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | ONYX THERAPEUTICS, INC. | ||
| Patents | 7,232,818; 7,417,042; 7,491,704; 7,737,112; 8,129,346; 8,207,125; 8,207,126; 8,207,127; 8,207,297; 9,511,109 | ||
| Attorneys | R. Touhey Myer | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-12-19 | 1 | or more claims of the Orange Book Patents. U.S. Patent Nos. 7,232,818; 7,491,704; 8,129,346; 8,207,125…-2714 in the Orange Book are U.S. Patent Nos. 7,417,042; 7,232,818; 7,491,704; 8,129,346; 8,207,125; … THE PATENT-IN-SUIT 17. United States Patent No. 7,737,112 (the “’112 Patent”), entitled… This is a civil action for patent infringement under the patent laws of the United States, Title…Product prior to the expiration of U.S. Patent No. 7,737,112 (“the Patent-in-Suit”), which is owned by Onyx | External link to document | |
| 2019-05-08 | 16 | Order | enjoined from infringing United States Patent Number 7,737,112 on its own part or through any Affiliate…December 2017 8 May 2019 1:17-cv-01833 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
